Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Responsibilities Lead and manage antibody-related research programmes, including antigen strategy, antibody discovery, screening, engineering, validation, and downstream translational applications in biomarker
-
diseases, with the goal of advancing therapeutic and vaccine design. The successful candidate will lead structure-based studies of glycoproteins, antibodies, and their complexes, taking projects from protein
-
Number: R146286 The PIIO is developing the Center for Antibody Therapeutics (CAT) for producing therapeutic antibodies to fuel pre-clinical and clinical development. Antibody-based drug modalities will
-
work on antibody isolation, engineering or rational design. 3. Experience mentoring junior researchers or supervising laboratory personnel. Create a Job Match for Similar Jobs Logo About The Ohio State
-
24 Apr 2026 Job Information Organisation/Company Leiden University Research Field Biological sciences » Biological engineering Biological sciences » Biology Pharmacological sciences » Pharmacy
-
10 Apr 2026 Job Information Organisation/Company CNRS Department XLIM Research Field Engineering Physics Technology Researcher Profile Recognised Researcher (R2) Application Deadline 30 Apr 2026
-
of supplies, clean equipment. Other duties as assigned. In addition to the duties described above Construct Engineering: Design and assemble DNA vectors for bispecific antibodies using advanced cloning
-
biologics engineering campaigns guided by structural biology and biophysical principles. Translate computational outputs into biologically meaningful insights relevant for protein/antibody design in support
-
7 Apr 2026 Job Information Organisation/Company Université de Tours Research Field Chemistry Biological sciences » Biological engineering Medical sciences Researcher Profile Recognised Researcher
-
. As described above, the field of cancer immunotherapy is rapidly advancing. The opportunities to develop conceptually new cancer therapies are endless with the help of antibody technology, such as